Magle Chemoswed Holding AB announces change of Certified Adviser to Vator Securities
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Magle Chemoswed Holding AB (publ) hereby announces that the company has entered into an agreement with Vator Securities AB (“Vator Securities”) regarding the service as a Certified Adviser. Vator Securities will be appointed Certified Adviser (CA) on January 1, 2023. Up until then, Västra Hamnen Corporate Finance will continue to act as Certified Adviser for the company.
Contacts
Megi Medzmariashvili, Legal Counsel, phone +46 (0)76 164 33 12, megi.medzmariashvili@maglechemoswed.com
About Us
The Magle Group aims to establish itself as a leader in high-quality life-changing healthcare innovations to meet medical needs through scientific excellence. The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. Today, the Group includes two operational areas. Magle Chemoswed – a contract development and manufacturing organization (CDMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle PharmaCept – an established sales and marketing company for development and direct sales of the Group’s medical technology products. Learn more on www.maglechemoswed.com and https://maglegroup.com/ and www.maglepharmacept.com
Västra Hamnen Corporate Finance is the Company's certified advisor on Nasdaq First North Growth Market.
The information was submitted for publication, through the agency of the contact persons set out above, at 2022-10-04 at 16:30 CEST.